| 000 | 00961 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250517052751.0 | ||
| 264 | 0 | _c20161101 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2015.63.5938 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchwartz, Gary K | |
| 245 | 0 | 0 |
_aTrabectedin and the L-Sarcomas: A Decade-Long Odyssey. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 2016 |
||
| 300 |
_a769-71 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 34 _gno. 8 _gp. 769-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2015.63.5938 _zAvailable from publisher's website |
| 999 |
_c25262464 _d25262464 |
||